Pharmaceuticals, Biotechnology and Life Sciences
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–#INDstatus—PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing targeted cellular therapies for cancer and…
– Omeros Remains On Track to Initiate the Submission Next Quarter – SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER) announced that the…
Merz opens new dermal filler manufacturing site in Dessau, invests 15 million Euro to expand its presence in BioPharmaPark Oncotec,…
Prices projected to increase over previous estimates, driven by newly released products such as cellular and gene therapies CHARLOTTE, N.C.–(BUSINESS…
Secured leading US market position in generic anti-infective portfolio Updated US commercial structure to meet expansion of innovative portfolio First…
A joint venture between Atropos and Atomwise will discover and develop anticancer agents using senescence assay and AI technologies SAN…
– Multi-Year Observational Study Designed to Evaluate Outcomes of Patients with Hematologic Malignancies Who Undergo Allogeneic Bone Marrow Transplantation –…
BEDFORD, Mass.–(BUSINESS WIRE)–Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of…
Oregon Bio 2019: Innovating and Scaling for our Region’s Growth is the annual conference aimed at investors, start-up entrepreneurs, executives,…
SARM1 knock-out in an EAE mouse model demonstrates evidence of axonal protection CAMBRIDGE, Mass.–(BUSINESS WIRE)–Disarm Therapeutics, a biotechnology company creating…